"In support of the clinical mission, there is a robust basic science and clinical research enterprise focusing on changing the course of diseases such as amyotrophic lateral sclerosis, multiple sclerosis, epilepsy, stroke and Parkinson's disease."
In a piece written for The Conversation, Fen-Biao Gao, PhD, talks about how frontotemporal dementia changes the brain and the research that is untangling its genetic causes.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Faculty, Research, Rare Disease, Conversation, Fen-Biao Gao Lab, Neurology, Li Weibo Institute for Rare Diseases Research, Latest News,
Researchers working with UMass Chan Medical School’s Translational Institute for Molecular Therapeutics announced progress in developing a vector to deliver gene replacement therapy in mice models with Cockayne syndrome, a rare and fatal neurodegenerative disease that largely affects children and young adults.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Faculty, Research, Rare Disease, Rare Diseases, Miguel Sena-Esteves, Neurology, Latest News,
Research News
Top story: Motor neuron toxin associated with ALS identified by UMass Chan investigators
Top story: An international team of investigators has discovered that an inorganic polyphosphate released by nerve cells known as astrocytes in people with ALS and frontotemporal dementia contributes to the motor neuron death that is the signature of these diseases.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Clinician, Faculty, Amyotrophic Lateral Sclerosis, Postdoctoral Scholar, Neurology,
